pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Type 2 Diabetes · news · pharmadog
← back to Type 2 Diabetes
News mentioning Type 2 Diabetes
40
stories
1d
Novo takes first round of oral obesity duel. Can it stay ahead of Lilly?
biospace
8d
STAT+: Pharmalittle: We’re reading about Lilly ‘black market’ lawsuits, pushback over Trump vaccine plan, and more
stat
9d
Stopping statins in people over 75 at low risk for heart disease didn’t increase deaths
stat
9d
Abbott teams with Google Health on AI-powered health insights app
fiercebiotech
11d
Recon: BMS plans $2.3B Houston manufacturing site; MHRA approves Lilly weight-loss drug for weight loss, type 2 diabetes
raps
15d
Lilly climbs, Novo falls as obesity drug battle intensifies
biopharma dive
15d
Amgen’s MariTide stands alone after obesity cull while analysts seek more M&A
biospace
15d
‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth
fiercebiotech
15d
Novo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data
fiercebiotech
16d
Amgen drops early-stage obesity drug, upping pressure on MariTide
fiercebiotech
21d
Chronically ill people face confusion over new Medicaid work rules and ‘medically frail’ exemption
stat
22d
FDA updates product-specific guidelines for injectable peptides
raps
22d
FDA unveils FY 2027 user fee rates
raps
23d
After PCOS became PMOS, there’s hope for new awareness among Black and Latina women
stat
24d
AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failure
biospace
27d
Roche cans one Carmot obesity asset as another shows best-in-class potential
biospace
28d
Lilly, with new data, to seek FDA approval of obesity drug retatrutide
biopharma dive
28d
Lilly preps FDA run for ‘triple-G’ weight loss drug with Phase 3 data
biospace
28d
Lilly’s triple-G drug hits 22.6% weight loss, but impact on reducing cardio risk is less clear
fiercebiotech
29d
FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilot
fda press
Jul 20, 26
Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence
biospace
Jul 9, 26
Opinion: Who benefits from classifying obesity as a disease?
stat
Jul 8, 26
Another big premium hike on the horizon
stat
Jul 8, 26
Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefits
stat
Jun 12, 26
FDA Clears First Over-the-Counter Continuous Glucose Monitor for Children
fda press
Jun 9, 26
Dexcom RCT suggests CGM benefits for broad diabetes population
stat
Jun 9, 26
Alcohol study discarded by Trump officials is published in scientific journal
stat
Jun 8, 26
ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ option
biopharma dive
Jun 4, 26
Scientists uncover a new hiding spot for HIV
stat
Jun 4, 26
Male puberty is understudied — but when it starts may predict long-term health risks
stat
← prev
page 1 of 2
next →
